What Bitfount does
Bitfount runs a federated AI and data-science platform that lets pharmaceutical companies, CROs, clinics and hospitals collaborate on clinical research and AI model training while keeping patient data on each organisation's own infrastructure. EU-Startups and Tech.eu report the London company, founded in 2020, raised $8m (£5.9m) in a Series A round with Parkwalk Advisors, Ahren Innovation Capital, Pace Ventures, Foresight Group and Portfolio Ventures, announced July 23, 2025. Bitfount's use cases include clinical-trial patient recruitment and site feasibility analysis, and its platform supports models built with PyTorch, ONNX and Hugging Face, plus integrations with EHR systems including Epic, Oracle Health and Athenahealth.
Bitfount is a healthcare tool on Falcoscan. Federated AI platform that lets hospitals collaborate without sharing patient data. Falcoscan rates Bitfount with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Bitfount is founded in 2020, currently at Series_a stage. Pricing: Freemium.